줄기세포 유래 세포치료제의 개발 전략 및 임상화 과정
= Strategy and Clinical Process for Development" of the Stem Cell-Derived Cell Therapy Products

제어번호 99559199
저자명 조명수 ( Myung Soo Cho )  ,유대훈 ( Dae Hoon Yoo )  ,송슬애 ( Seul Ae Song )  ,최영민 ( Young Min Choi ) 
학술지명 人口醫學硏究論集
권호사항 Vol.25 No.- [2012] 
발행처 서울대학교 인구의학연구소 
자료유형 학술저널
수록면 27-34(8쪽)
언어 Korean
발행년도 2012년
KDC 510
판매처 한국학술정보

 
초록
Stem cells are good cell sources for cell replacement therapy of degenerative or incurable disorders. However, there are some limitations such as immune response, differentiation efficiency, safety and ethical issues for clinical application. These barriers must be considered thoroughly from starting point of the investigational study. For clinical application and commercialization of stem cell-derived cell therapy products, strict preparation is required for formal approval of regulatory body at each stage of the clinical process. This preparation process can be another barrier and challenge to the researcher or developer related to stem cell study. However, These challenges will become increasingly important to stem cell research as clinical translation progresses and helpful for birth of authentic novel cell therapy products. In this brief review, we will suggest more effective strategy of the stem cell research and development and introduce the clinical process for cell therapy products briefly

주제어
stem cells  ,cell therapy products  ,embryonic stem cells  ,adult stem cells  ,clinical trial